Enyo Pharma
ID: 5425538Developer of FXR agonists for the treatment of severe kidney diseases.
3
Funding Rounds
$104.5m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ja*** Vo********* |
|
- | |
| La****** Me*************** | - | - | - |
| Be***** de Ch***** |
|
- | - |
| Pa***** An**** | - | - | - |
| Vi***** Lo***** | - | - | - |
| Je********** Ga**** |
|
- | - |
Funding
Funding series
Funding Series Analysis
The company Enyo Pharma has raised a total of $51m in funding over 3 rounds.
Key Insights:
- Enyo Pharma Series C Round, June 2025: $7m
- ENYO Pharma June 2018 Series B Funding Round: $44m
- ENYO Pharma funding round, June 2018: $53.5m
Industries
Enyo Pharma is active in the following industries: